Taylor & Francis Journals: Welcome 
Contact Us Careers Members of the Group
Taylor & Francis Journals: Welcome 
Search for Books Journals and eBooks
Journal Listings
Alphabetical Listing
Journals by Subject
New Journals
Author Resources
Author Services
Authors' Newsletter
Copyright & Author Rights
Instructions for Authors
Journals Resources
Advertising
Catalogues
Customer Services
Developing World Initiatives
Email Contents Alerting
eUpdates
Online Information
Online Sample Copies
Permissions
Press Releases
Price List
Publish with Us
Reprints
Special Issues
Special Offers
Subscription Information
Related Websites
Arenas
LibSite
Society Publishing
Routledge Books
Taylor & Francis Books
eBooks

Journal Details

Printer Friendly Page
Anthropology & Medicine

Anthropology & Medicine


Published By: Routledge
Volume Number: 17
Frequency: 3 issues per year
Print ISSN: 1364-8470
Online ISSN: 1469-2910
 

Forthcoming Articles

Special issue -
New Anthropologies of Medical Compliance
Volume 17, Issue 2, 2010

Guest editors:
Kal Applbaum -
University of Wisconsin-Milwaukee
Michael Oldani - University of Wisconsin-Whitewater

Over the last two decades healthcare practices concerning “medical compliance” and/or “treatment adherence” have undergone significant transformations. In particular, the pharmaceuticalization and the closely related corporatization of treatment plans have, at times, radically shifted what it means for both patients and healthcare providers “to be compliant.” Global compliance models continue to be produced that rely on numbers-based outcomes measurements that are aimed at transcending healthcare borders.

The authors of this special issue use clinical ethnographic methods in a variety of local geographies to scrutinize these new practices at various sites along the compliance continuum. Contributors conducted fieldwork in Canada, the U.S., Russia, and Barbados. Critical questions addressed through these papers include: How do parents and children differ in their interpretations of treatment compliance in adolescent bi-polar disorder? How does the “relative value” of patients treated for diabetes determine their compliance status; future likelyhood of treatment; and doctor bonus payments? How do college students become self-compliant when using psychotropic medication to treat mood disorders? What are the dynamics of compliance between pharmaceutical companies (and contract research organizations) and clinical trial subjects? How do anxieties between patients and doctors (and biomedicine versus traditional medicine) impact treatment compliance for childhood asthma? What factor does willpower play when structuring alcohol treatment programs for large populations? What role does (bio)ethics play in creating compliance regimens for community psychiatric treatment programs? How does trust and the the notion of the “good nurse” impact Alzheimer's treatment adherence? And finally, what does compliance mean at the “end-of-life” for terminally ill cancer victims?
 
Collectively, these papers will stress the perspectives of a variety of local stake-holders, while critically assessing the human benefits (and costs) incurred through new and emergent practices of medical compliance.

Original Papers

Introduction: “New Anthropologies of Medical Compliance”
Applbaum and Oldani

Between Compliance and Willpower: Treating Alcoholism in St. Petersburg, Russia
Eugene Raikhel

Thinking Outside the Compliance Box: Social and Symbolic Practices of Psychiatric Medication Consumption among University Students
Kelly McKinney and Brian Greenfield

A Philosophy without Philosophers: Medical Compliance at the End of Life
Carolyn Rouse

Youth and Psychiatric Medication: Desire and Disappointment
Jerry Floersch and Jeffrey Longhofer

Diagnosing Desire: Anxieties in the Discourse of Compliance
Ian Whitmarsh

The Poetics of Caring: Trust, Compliance, and the Good Nurse
Annette Leibing

Compliance and Coercion: Emergent Ethical Debates Among Front-Line Clinicians in Community Psychiatry
Paul Brodwin

Taking Drugs For Money: Examining New Forms of Medical Compliance and Resistance among Professional Clinical Trial Subjects in the U.S.
Roberto Abadie/Hunt

From “Good Numbers” to “Drop-em” Status: Assessing the Relative Value of Diabetic Patients Treated Through a Corporate Compliance Model
Michael Oldani

top top
Copyright © 2009 Taylor & Francis Group, an informa business   Privacy Policy   Terms and Conditions